Modulators of the hedgehog signaling pathway

The hedgehog (hh) pathway is the basis of an important new class of therapeutic agents with far-reaching implications in oncology. In this review, we trace the story of cyclopamine, the first reported inhibitor of hh signaling, give an overview on the biological modes of this pathway, and finally present potent modulators-many of them already in clinical studies.